Not sure on either of those questions. We don’t have insight into supplier, name or location.
Not sure it’s right time for company to sell yet. Generic oxy hurdles may be solved near term to launch. Also, lots of money funneling to R&D in what we know are billion dollar markets. Crickets there since Methotrexate positive BE. Would be good to see a couple quick solid BE’s after quick succession. CEO said they are on track, but that is inconsistent with expectations from couple cc’s ago.